Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Guided Ablation System Treats Cardiac Arrhythmias

By HospiMedica International staff writers
Posted on 30 Aug 2021
A novel cardiac mapping and ablation platform enables examination and treatment of target tissues with precision and accuracy.

The CardioNXT (Westminster, CO, USA) platform is comprised of two physical tools, Axis wearable patient patches and the MultiLink internal reference catheter, both outfitted with electromagnetic and impedance sensors to identify the exact location of the tissue causing an arrhythmia. More...
Sensor readings are processed by the platforms iMap three dimensional (3D) Navigation & Mapping system and Activate software system so as to construct a 3D model of the heart, and also provide guidance during ablation procedures.

The iMap System uses dynamic referencing based 3D Navigation via a patented combination of dual tracking modalities (electromagnetic and impedance) that are generated by the proprietary internal reference MultiLink Catheter. During the subsequent cardiac ablation procedure, Activate software helps determine position coordinates for the surgical instruments in order to define precise location (relative to the constructed 3D heart model), and then guide the clinician safely towards the selected ablation site.

“CardioNXT has taken my advice to heart. I'm excited to see the improvements that can be made in the treatment of AFib patients with this technology. Treatment paradigms beyond PVI are still to be determined and we need systems like this one to help us evolve treatment strategies,” said Vivek Reddy, MD, director of cardiac arrhythmia service at Mount Sinai Hospital (New York, NY, USA). “My advice to all is that there must be a tight integration between complex mapping and accurate navigation in order for any map of the heart to be useful in the treatment of patients, especially complex cases such as persistent atrial fibrillation.”

AF ablation is a minimally invasive approach to create lesions (scar tissue) that interrupt irregular electrical signals in the heart, in a procedure known as pulmonary vein isolation (PVI). Since the pulmonary veins are often the major source of the cardiac arrhythmia, PVI via catheter ablation remains the cornerstone treatment for AF patients who are unresponsive to drug therapy.

Related Links:
CardioNXT


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.